Dutch healthcare system and reimbursement procedures expertise
Functional leadership of cross-functional launch teams
This newly created strategic position leads the launch of a new cardiovascular drug in 2028 while managing the broader non-oncology portfolio
Job Summary
This newly created strategic position leads the launch of a new cardiovascular drug in 2028 while managing the broader non-oncology portfolio.
The role requires designing comprehensive patient access plans and navigating complex reimbursement processes with key Dutch stakeholders like ZIN and cieBAG.
Candidates will receive competitive compensation including a company car, 35.5 days of leave, and a solid pension plan within a global dynamic environment.
Matching Summary
This newly created strategic position leads the launch of a new cardiovascular drug in 2028 while managing the broader non-oncology portfolio.
Salary
Competitive salary; 3% year-end bonus; Company car included
Skills & Requirements
Must-have
7+ years pharmaceutical market access experience
Dutch healthcare system and reimbursement procedures expertise
Functional leadership of cross-functional launch teams
Health economics and HTA dossier preparation skills
Stakeholder management with ZIN and Ministry of Health
Nice-to-have
Strong strategic thinking and analytical capabilities
Excellent negotiation and relationship building skills
Experience with cardiovascular or non-oncology portfolios
Fluency in both Dutch and English languages
Key Requirements
University degree in health economics, pharmacy, or life sciences
Minimum 7 years of experience as a market access manager or lead
In-depth understanding of Dutch regulatory pathways (ZIN, GVS, cieBAG)